Skip to content
CNA Finance
  • Biotech Stocks
  • Cannabis Stocks
  • Tech Stocks
  • Basic Materials Stocks
  • Service Stocks
  • Personal Finance
    • Investing Product Reviews
      • Betterment Review
      • Motley Fool Review
      • Investors Underground Review
      • Roofstock Review
      • M1 Finance Review
      • Bloom Review
  • Selling Cars That Don’t Run

SAVA

SAVA Stock: Cassava Sciences Flies on Fast Track Designation

February 22, 2021 by Joshua Rodriguez
Cassava Sciences SAVA Stock News

Cassava Sciences Inc (NASDAQ: SAVA) is rocketing in the market this morning, and for good reason. The company announced the completion of an End-of-Phase 2 meeting with the FDA and will be moving forward with a pivotal Phase 3 study soon. Here’s what’s going on: Skip to What You Want to Read Cassava Sciences Gains … Read more

Categories Biotech Stocks Tags Large Cap Stocks, SAVA

Search CNA Finance

Hot Off The Press

  • METX Stock: Meten EdtechX Education Climbs on Billings Growth
  • LIXT Stock: Here’s Why Lixte Biotechnology is Soaring
  • NAK Stock: Northern Dynasty Flies on Appeal News
  • KOSS Stock: Redditors Are at it Again!
  • MICT Stock: This License Can Make MICT a Blockbuster
© 2021 CNA Finance • Built with GeneratePress